In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Apotex Inc.

www.apotex.com

Latest From Apotex Inc.

Apotex Can Push Ahead With Canadian Perindopril Combination

Servier’s Canadian perindopril arginine salt patent is invalid for being obvious and for having patent claims wider in scope than the invention.

 

Canada Intellectual Property

Strides' US Revenues Soar As Recovery Strategy Is ‘Executing To Plan’

Strides Pharma is “very confident” about future after the Indian company’s fourth-quarter US revenues rocketed by 181% and EBITDA margins beat market expectations.

Commercial Sales & Earnings

Strides' US Revenues Soar, Recovery Strategy ‘Executing To Plan’

Strides Pharma “very confident” about future after Indian generic company’s fourth-quarter US revenues rocketed 181% and EBITDA margins beat market expectations.
Commercial Sales & Earnings

Greater Clarity Needed On CGT Pathway In US

Several aspects of the FDA’s draft guidance on the pathway for competitive generic therapies require clarification, according to detailed feedback submitted by industry.

Policy & Regulation Regulation
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register